The plan first addresses monoclonal antibodies but could eventually be applied to all compounds seeking FDA approval.
Emily Duerson, PharmD Candidate
Advertisement
Articles by Emily Duerson, PharmD Candidate
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
Subcutaneous Formulation of Guselkumab Receives FDA Approval in Ulcerative Colitis
2
FDA Grants Accelerated Approval to Elamipretide, First Treatment for Barth Syndrome
3
Confronting the Mental Health Crisis: Structural Inequities, Market Pressures, and the Role of Pharmacy Solutions
4
Teen Angst, Adolescent Anguish: Could It Be Mental Illness?
5
